By Redmond Media Lab
The podcast currently has 17 episodes available.
Subscribe at https://bit.ly/LeadersAgendaYT
Learn More at https://leadersagenda.com/
Subscribe at https://bit.ly/LeadersAgendaYT
Learn More at https://leadersagenda.com/
More from David:
Book, The Digital Transformation Roadmap: https://amzn.to/41U85dl
Download a free book chapter: https://bit.ly/subscribe-DX
Free newsletter: https://bit.ly/digital-substack
David's website: https://davidrogers.digital
Columbia Business School 4-day executive program, Leading Digital Transformation: https://bit.ly/DXRoadmap-Class
David Rogers is the world’s leading expert on digital transformation, a member of the faculty at Columbia Business School, and the author of five books. In his newest book, "The Digital Transformation Roadmap" (2023), Rogers tackles the barriers behind the 70% of businesses that fail in their own digital efforts. He shows why every business must transform not just its products―it must transform the organization itself. Rogers offers a five-step roadmap to rebuild any organization for continuous digital change.
His previous landmark bestseller, The Digital Transformation Playbook (2016), was the first book on digital transformation and put the topic on the map. Now published in thirteen languages, it defined the discipline by arguing that digital transformation (DX) is not about technology; it is about strategy, leadership, and new ways of thinking. Rogers has helped companies around the world transform their business for the digital age, working with senior leaders at corporations including Google, Microsoft, Citigroup, Visa, HSBC, Unilever, Procter & Gamble, Merck, GE, Toyota, Cartier, Pernod Ricard, China Eastern Airlines, NC Bank Saudi, and Acuity Insurance, among others. Rogers regularly delivers keynotes at conferences on all six continents and has appeared on CNN, ABC News, CNBC, Channel News Asia, and in The New York Times, The Financial Times, The Wall Street Journal, and The Economist.
At Columbia Business School, Rogers is faculty director of executive education programs on digital business strategy and on leading digital transformation. He has taught over twenty-five thousand executives through his programs in New York City, in Silicon Valley, and online. His recent research has focused on new business models, innovating through experimentation, governance for growth, and barriers to change in digital transformation.
Eduardo Briceño is a global keynote speaker, facilitator, and author who guides many of the world’s leading companies in developing cultures of learning and high performance. His TED and TEDx talks have been viewed more than nine million times. He is the author of The Performance Paradox, which was selected as a "Must-Read" by the Next Big Idea Club. He was shortlisted by Thinkers50 -- which are the "Oscars of management thinking" -- for the Breakthrough Idea Award, given to thinkers who “have ignited Eureka moments in management, offering radical ideas that have the potential to reshape the future of business as we know it.”
Ranjeet Banerjee is an extremely successful and experienced medical technology executive who has spent the last 25 years with Becton Dickinson (“BD”), a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics, and the delivery of care. Most recently, he was a BD Corporate Executive Vice President as well as President of the US and Canada regions with responsibility for $6 billion in revenue. Over his career at BD, Ranjeet has been responsible for growing businesses in the Americas, Europe, and Asia, pioneering new business models, and developing innovative product and service offerings to deliver a differentiated experience to BD’s customers. Ranjeet earned a Bachelor of Technology in Chemical Engineering from the Indian Institute of Technology and brings a wealth of experience in growing branded, medical-oriented, high-technology businesses both organically and through acquisition.
The last mile of the Life Sciences value chain is crucially important when transporting drugs, vaccines, and biologics that must remain within controlled conditions (temperature, humidity, etc.). Poor conditions and even small excursions can significantly impact the quality and efficacy of the products. Building the right strategy for the last mile should never be an afterthought! It was shocking to learn that an estimated $40-50B is lost annually due to inefficiencies and poor conditions that lead to waste (=products being discarded)!
As Ranjeet noted, "the pace of technology and innovation is often faster than the pace of collaboration". To stop the waste, no one company can "do it alone". Listen to Ranjeet describe what it would take to build a game-changing strategy and path to stop the waste and truly advance life sciences value chain innovation.
Today’s episode on the #LeadersAgenda features an intimate conversation between SameYou co-founder Jenny Clarke and show host Tarja Huuskonen. #SameYou was founded by Jenny Clarke, and her daughter, Emilia Clarke, whose decision to go public about her own experience has encouraged many others to break the silence.
In this episode, they discuss what it takes to start a movement, the power of patient stories, and what SameYou is doing to change how we think about brain injury recovery.
To change patients’ lives, we must pause to hear their voices, even when we think they don't concern us. They do. They always do.
Learn more about SameYou at https://www.sameyou.org/
Learn more about Leaders Agenda at https://leadersagenda.com/
#braininjury #brainhealth #mentalhealthawareness #neuroscience
In our latest episode, host Tarja Huuskonen sits down with Kristophe Diaz to talk about what needs to change in the business of treating rare diseases. Kristophe Diaz, the Executive Director & Chief Scientific Officer at CurePSP, is a scientist turned patient advocate in the rare-disease space --- connecting dots with patients, families, providers, and life sciences companies. He is determined, bold, and results-oriented in changing how patient needs are heard, understood, and turned into innovative products and services through collaborative efforts.
Watch the full 4K video of this episode for free on YouTube!
The technologies and processes needed to manage data and turn it into intelligence are often obscure and just out of reach from most organizations. However, our latest guest on the Leader’s Agenda, Barbara Salami (VP of Digital at Moderna), describes this feat of digital transformation not as a chore but instead as an opportunity to build best-in-class, frictionless experiences for Moderna’s external stakeholders.
Today's episode of the Leader's Agenda brings together 3 seasoned practitioners, Suzanne Giroux, Vice President, PMO - R&D at BD, Mehdi Hirji, VP, Portfolio & Program Management at Bio-Rad, and Gary Chin, VP, Innovation & Product Development at Action for Results, hosted by Tarja Huuskonen, to discuss one of the hottest topics in the life sciences industry: outcome driven innovation and value driven project management.
In this thorough and collaborative conversation, our panel explores:
Finally... we explore whether or not the result we measure be meeting a launch date and other internal deliverables or we should look beyond that. Should we instead ask what value the product and project brought to the customer, the patient, and the business, measuring those metrics? What do you think? Let us know in the comments below!
Innovation without the right outcomes is a recipe for failure for both the project and the business. This simple notion seems obvious, yet countless companies get it wrong from the start, never realizing the missed opportunities for winning products with sustainable value! As a result, mediocre products go out the door to customers every day. In the worst cases, medical device companies have invested 6 to 10 years in a product's development, only to find out that it was the wrong product!
So, how do we remedy this issue? Our recent guest, Tony Ulwick might just have the answer!
Tony is the pioneer of Jobs-to-be-Done Theory, the inventor of the Outcome-Driven Innovation® (ODI) process, and the founder of strategy and innovation consulting firm Strategyn. Tony has applied his ODI process at some of the world’s leading companies and across nearly all industries to inform breakthrough innovations—achieving a success rate that is 5 times better than the industry average. Philip Kotler calls Tony “the Deming of innovation” and credits him with bringing predictability to innovation. Published in Harvard Business Review and MIT Sloan Management Review, Tony is also the author of best sellers What Customers Want and JOBS TO BE DONE: Theory to Practice
Our latest episode of the Leader's Agenda features Kenneth Burhop, a lifetime innovator within Life Sciences. Ken recently retired from his position as the Chief Scientific Officer at Integra LifeSciences! Before Integra, Ken worked at Baxter International Inc. as their Global Scientific Lead and VP of R&D cumulatively for 25 years!
Tarja Huuskonen had a chance to sit down with Ken and ask him how he has built innovation agendas in companies both large and small and what advice he has for others trying to develop not just one breakthrough but a pipeline of innovation.
The podcast currently has 17 episodes available.